AUSTRALIA
Australia | Lessons from recent interlocutory injunctions in pharmaceutical patent cases 
Is it becoming easier to obtain interlocutory injunctions in Australian pharmaceutical patent cases? We provide an overview of recent decisions in Australia’s Federal Court that shine a light on some key lessons for patent owners.  Overview  In...
Is it becoming easier to obtain interlocutory injunctions in Australian pharmaceutical patent cases? We provide an overview of recent decisions in Australia’s Federal Court that...
Read More
AUSTRALIA
Australia | Patents: the evolving law of Support and Sufficiency 
For more than a decade, and for at least another decade to come, Australia’s patent law has openly applied a double-standard with respect to written description requirements, namely the...
For more than a decade, and for at least another decade to come, Australia’s patent law has openly applied...
Read More
AUSTRALIA
Legal 500 Country Guide | Patent litigation in Australia
Spruson & Ferguson Lawyers has again provided expert content for the 2025 edition of the Legal 500 Country Guide to patent litigation laws and regulation in Australia. These useful guides...
Spruson & Ferguson Lawyers has again provided expert content for the 2025 edition of the Legal 500 Country Guide...
Read More
Skinny labelling in the Australian context: an overview
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be protected by several different patent claim formats, including method of...
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be...
Read More
AUSTRALIA
Infringement of second medical use claims | Federal Court decision adds guidance
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known substances arise frequently. In this article, we discuss the recent...
In pharmaceutical patent litigation, issues concerning infringement of method of treatment and Swiss-style claims covering new indications for known...
Read More
The 2023 IP year in review, and predictions for 2024
In Australia, February signals a return from the beach, children back to school after a long summer break and of course the usual traffic woes! At Spruson & Ferguson Lawyers,...
In Australia, February signals a return from the beach, children back to school after a long summer break and...
Read More
AUSTRALASIA
What the High Court Decision in Aristocrat means for patent owners
The High Court of Australia issued a split decision in Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents on 17 August 2022. As reported in our previous article,...
The High Court of Australia issued a split decision in Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents...
Read More
AUSTRALASIA
Pfizer preliminary discovery attempt on ERELZI fails
In this Federal Court case, Pfizer’s attempt to obtain documentation from Sandoz regarding its ERELZI etanercept product failed, Justice Burley finding that undertakings provided by Sandoz to give notice...
In this Federal Court case, Pfizer’s attempt to obtain documentation from Sandoz regarding its ERELZI etanercept product failed, Justice...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe